Annual Retained Earnings
-$456.39 M
-$121.83 M-36.42%
31 December 2023
Summary:
Prelude Therapeutics Incorporated annual retained earnings is currently -$456.39 million, with the most recent change of -$121.83 million (-36.42%) on 31 December 2023. During the last 3 years, it has fallen by -$348.96 million (-324.84%). PRLD annual retained earnings is now -1890.62% below its all-time high of -$22.93 million, reached on 31 December 2018.PRLD Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$554.83 M
-$32.27 M-6.18%
30 September 2024
Summary:
Prelude Therapeutics Incorporated quarterly retained earnings is currently -$554.83 million, with the most recent change of -$32.27 million (-6.18%) on 30 September 2024. Over the past year, it has dropped by -$131.52 million (-31.07%). PRLD quarterly retained earnings is now -998.74% below its all-time high of -$50.50 million, reached on 31 December 2019.PRLD Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRLD Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.4% | -31.1% |
| 3 y3 years | -324.8% | -197.8% |
| 5 y5 years | -1890.6% | - |
PRLD Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -324.8% | at low | -197.8% | at low |
| 5 y | 5 years | -1890.6% | at low | -998.7% | at low |
| alltime | all time | -1890.6% | at low | -998.7% | at low |
Prelude Therapeutics Incorporated Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$554.83 M(+6.2%) |
| June 2024 | - | -$522.56 M(+7.1%) |
| Mar 2024 | - | -$487.82 M(+6.9%) |
| Dec 2023 | -$456.39 M(+36.4%) | -$456.39 M(+7.8%) |
| Sept 2023 | - | -$423.31 M(+7.8%) |
| June 2023 | - | -$392.71 M(+8.4%) |
| Mar 2023 | - | -$362.28 M(+8.3%) |
| Dec 2022 | -$334.56 M | -$334.56 M(+9.4%) |
| Sept 2022 | - | -$305.92 M(+10.9%) |
| June 2022 | - | -$275.96 M(+11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$248.59 M(+13.4%) |
| Dec 2021 | -$219.12 M(+104.0%) | -$219.12 M(+17.6%) |
| Sept 2021 | - | -$186.28 M(+19.7%) |
| June 2021 | - | -$155.59 M(+20.9%) |
| Mar 2021 | - | -$128.73 M(+19.8%) |
| Dec 2020 | -$107.43 M(+112.7%) | -$107.43 M(+21.8%) |
| Sept 2020 | - | -$88.18 M(+23.5%) |
| June 2020 | - | -$71.42 M(+41.4%) |
| Dec 2019 | -$50.50 M(+120.3%) | -$50.50 M |
| Dec 2018 | -$22.93 M | - |
FAQ
- What is Prelude Therapeutics Incorporated annual retained earnings?
- What is the all time high annual retained earnings for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual retained earnings year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly retained earnings?
- What is the all time high quarterly retained earnings for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly retained earnings year-on-year change?
What is Prelude Therapeutics Incorporated annual retained earnings?
The current annual retained earnings of PRLD is -$456.39 M
What is the all time high annual retained earnings for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual retained earnings is -$22.93 M
What is Prelude Therapeutics Incorporated annual retained earnings year-on-year change?
Over the past year, PRLD annual retained earnings has changed by -$121.83 M (-36.42%)
What is Prelude Therapeutics Incorporated quarterly retained earnings?
The current quarterly retained earnings of PRLD is -$554.83 M
What is the all time high quarterly retained earnings for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly retained earnings is -$50.50 M
What is Prelude Therapeutics Incorporated quarterly retained earnings year-on-year change?
Over the past year, PRLD quarterly retained earnings has changed by -$131.52 M (-31.07%)